November 21st 2024
CMS Medicaid chief foreshadows potential policy changes coming when President-elect Trump moves into the White House.
November 20th 2024
The U.S. Preventive Services Task Force highlights key research gaps in their recommendations intended to promote public health for all.
Brooks-LaSure describes achievements in her final national leadership call.
Study shows that most beneficiaries skip comparing Part D plans that might better suit their needs and their wallet
A recent market analysis outlined the lack of adequate health insurer competition in many U.S. markets.
Medicare proposes 2.6% reimbursement increase for outpatient care
Higher standards for obstetrical services are also part of the CMS proposal
FTC interim report shows top six PBMs control 94% of prescription fills and profit at the expense of patients
Some PBMs have ignored government compliance orders despite having two years to comply
PAI: Advice for physicians getting involved with private equity investors
Physicians Advocacy Institute CEO discusses consolidation in health care.
PAI: Possible solutions to alleviate problems in health care consolidation, part 2
PAI: Possible solutions to alleviate problems in health care consolidation, part 1
PAI: Corporate changes in the health care marketplace, part 3
PAI: Corporate changes in the health care marketplace, part 2
PAI: Corporate changes in the health care marketplace, part 1
PAI: Site-neutral payment for hospitals and physicians
PAI: Four areas of focus
PAI: Introducing the Physicians Advocacy Institute
CEO discusses consolidation in health care.
Supreme Court rules on Idaho emergency abortion case
Physicians, hospitals weigh in on health-related judgment.
Congressional perspectives: PBM reforms
How lawmakers can regulate PBMs.
Senator takes aim at prior auths, ‘number one administrative burden to physicians’
Regarding Medicare physician reimbursement, Marshall says doctors should ‘ask them why they're cutting your pay.’
Value-based care is the future of health care, but we need leadership to get there
The broken fee-for-service model, in combination with CMS’ efforts to contain costs, promises to cripple our health care delivery system unless providers transition to a value-based care model – and soon.
Corporate owners put profits ahead of patients and doctors, physician group says
Physicians Advocacy Institute comments on federal request for information about consolidation in health care.
Drug pricing now and to come – it’s complicated
Analysts ponder value, transparency and the effects of the Inflation Reduction Act.
The FTC’s noncompete rule is a concerning development for physicians
The ruling is going to be difficult to interpret and enforce.
ACP renews call for physicians to vote, make health care an issue for presidential election year
Physicians group leaders comment as part of annual gathering this month.
The vaccine pricing assault that threatens public health
Unpacking vaccine pricing: navigating policy, economics, and public health imperatives.
Interoperability: some improvement, but much work remains
New study finds uneven progress in making data exchange easier and more useful
Congressman on PBMs: ‘They've essentially become extortion artists’
Rep. Greg Murphy, MD, discusses prior authorizations and other pending legislation in Washington.
IVF, cancer, prescription drugs among health care issues in president’s State of the Union 2024 address
Abortion and AI also in the mix at the national level.
President, Big Pharma, PBMs wrangle over high drug prices
Critics air concerns at White House roundtable as pharmacy benefit manager volley back.
Congress needs to crack down on PBMs, state attorneys general say
More than half of the nation’s state top lawyers pen letter to leaders in House and Senate.
Medicare to cap out-of-pocket spending on Part D prescription drugs at $2,000
Change takes effect in 2025 and could benefit more than one million Medicare beneficiaries
Introducing AIMPA: How physicians are using AI in health care
A new advocacy organization for independent physicians.
Introducing AIMPA: How private equity could help medicine
Introducing AIMPA: State regulation of medicine
Introducing AIMPA: Starting a new national group